Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

ASCENDIS PHARMA A/S

(ASND)
  Report
Delayed Nasdaq  -  04:00:01 2023-02-07 pm EST
116.35 USD   +1.93%
02/07Ascendis Pharma Announces Full Year 2022 Financial Results and Business Update Conference Call on February 16
AQ
01/18Tech Stocks Lead European Equities Modestly Higher in Wednesday Trading
MT
01/17Pharma Stocks Lead European Equities Higher in Tuesday Trading
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Sector news Bio Therapeutic Drugs
02/07Transcript : Vertex Pharmaceuticals Incorporated, Q4 2022 Earnings Call, Feb ..
CI
02/07Insider Sell: Regeneron Pharmaceuticals
MT
02/07Vertex Pharmaceuticals Sets $3 Billion Share Repurchase Program
DJ
02/07Vertex Pharmaceuticals Q4 Adjusted Profit, Revenue Advance; Issues 2023 Product Revenue..
MT
02/07Earnings Flash (VRTX) VERTEX PHARMACEUTICALS INCORPORATED Posts Q4 Revenue $2.3B, vs. S..
MT
02/07Earnings Flash (VRTX) VERTEX PHARMACEUTICALS INCORPORATED Reports Q4 EPS $3.76, vs. Str..
MT
02/06SVB Securities Adjusts Price Target on Regeneron Pharmaceuticals to $834 From $770, Mai..
MT
02/06Morgan Stanley Adjusts Price Target on Regeneron Pharmaceuticals to $883 From $873, Mai..
MT
02/06Baird Adjusts Price Target on Regeneron Pharmaceuticals to $756 From $670, Maintains Ne..
MT
02/06RBC Trims Price Target on Regeneron Pharmaceuticals to $787 From $789 on Higher Estimat..
MT
02/03Insider Sell: Regeneron Pharmaceuticals
MT
02/03Regeneron Pharmaceuticals' Revenue Slides, Still Tops Street Views as R&D Spending Pick..
MT
02/03Transcript : Regeneron Pharmaceuticals, Inc., Q4 2022 Earnings Call, Feb 03, ..
CI
02/03Regeneron Pharmaceuticals' Q4 Non-GAAP Earnings, Revenue Decline
MT
02/03Regeneron Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter and Ful..
CI
02/03Regeneron Pharmaceuticals, Inc. announces an Equity Buyback for $3,000 million worth of..
CI
02/03Earnings Flash (REGN) REGENERON PHARMACEUTICALS Posts Q4 Revenue $3.41B, vs. Street Est..
MT
02/03Earnings Flash (REGN) REGENERON PHARMACEUTICALS Reports Q4 EPS $12.56, vs. Street Est o..
MT
02/03Regeneron quarterly profit drops 46%
RE
02/03Sanofi forecasts moderate profit growth on Dupixent demand
RE
02/02German Shares Zoom Up Thursday as ECB Delivers Rate Hike
MT
02/02BioNTech Says Construction of Plasmid DNA Manufacturing Facility in Germany Complete
MT
02/02BioNTech Finalizes EUR40 Million Plasmid DNA Manufacturing Facility in Germany
MT
02/02BioNTech SE Strengthens Manufacturing Capabilities with First In-House Plasmid DNA Manu..
CI
02/01BIONTECH : UBS remains Neutral
MD
01/31Insider Sell: Vertex Pharmaceuticals
MT
01/31Insider Sell: Vertex Pharmaceuticals
MT
01/31Goldman Sachs Adjusts Price Target on BioNTech SE to $156 From $177, Maintains Neutral ..
MT
01/31WuXi AppTec Forecasts Surge in 2022 Profit; Hong Kong Shares Down 3%
MT
01/30UBS Adjusts Vertex Pharmaceuticals Price Target to $373 From $342, Maintains Buy Rating
MT
01/30UBS Adjusts Regeneron Pharmaceuticals' Price Target to $863 From $862, Maintains Buy Ra..
MT
01/30BIONTECH : Gets a Buy rating from Berenberg
MD
01/30Cowen Upgrades Regeneron Pharmaceuticals to Outperform From Market Perform, Adjusts Pri..
MT
01/30South Africa Expects Delivery of Pediatric Pfizer/BioNTech COVID Vaccine Soon
MT
01/30Berenberg Bank Adjusts BioNTech SE's Price Target to $300 From $312, Maintains Buy Rati..
MT
01/30Analyst recommendations: Lockheed Martin, Macy's, Nordstrom, Reg..
MS
01/30Wuxi Apptec Co., Ltd. Provides Earnings Guidance for the Year Ended December 31, 2022
CI
01/30Regeneron Pharmaceuticals, Sanofi Says Dupixent Received Expanded Authorization in Euro..
MT
01/30Sanofi, Regeneron Secure First-in-Class Nod for Dupixent to Treat Eosinophilic Esophagi..
MT
01/30Sanofi and Regeneron's Dupixent wins new European Commission approval
RE
01/30Regeneron Pharmaceuticals, Inc. and Sanofi Announce European Commission Expands the Mar..
CI
01/27Insider Sell: Vertex Pharmaceuticals
MT
01/27Insider Sell: Vertex Pharmaceuticals
MT
01/27Pfizer, BioNTech Reportedly in Talks with EU Over Reducing COVID-19 Vaccine Orders
MT
01/27EU Mulls Changes to COVID-19 Vaccine Deal With BioNTech, Pfizer
MT
01/27Sector Update: Health Care Stocks Flat to Lower Premarket Friday
MT
01/27EU Might Buy Fewer Vaccine Doses From Pfizer, BioNTech for Higher Price, Reuters Report..
DJ
01/27Regeneron, Sanofi Say Dupixent Recommended for Expanded Approval in EU to Treat Atopic ..
MT
01/27Sanofi, Regeneron Win EU Panel's Backing for Dupixent to Treat Atopic Dermatitis in Chi..
MT
01/27Sanofi's and Regeneron's Dupixent wins new stage of EU regulatory approval
RE
01/27Sanofi/Regeneron: Dupixent wins new stage of EU regulatory approval
RE
01/26US CDC Continues Inquiry Into Potential Stroke Link from Pfizer, BioNTech Booster Shot
MT
01/26FDA advisers back the same COVID vaccine for initial shots, boosters
RE
01/25Insider Sell: Vertex Pharmaceuticals
MT
01/24Morgan Stanley Adjusts Price Target on Vertex Pharmaceuticals to $286 From $285, Mainta..
MT
01/24Decibel Therapeutics Gets UK Approval for Hearing Loss Clinical Trial in Pediatric Pati..
MT
01/24Morgan Stanley Adjusts Price Target on BeiGene to $325 From $295, Maintains Overweight ..
MT
01/24Morgan Stanley Raises Price Target on BioNTech to $216 From $203, Maintains Equal-Weigh..
MT
01/23BioNTech Finishes Construction of First Plasmid DNA Manufacturing Site in Germany
MT
01/20Asian Equities Rally in Friday Trading as ADRs Set to Close Week 2% Higher
MT
01/20Guggenheim Raises Price Target on BeiGene to $350 From $290, Maintains Buy Rating
MT
01/20SVB Securities Adjusts Price Target on BeiGene to $300 From $236, Maintains Outperform ..
MT
01/20JPMorgan Upgrades Regeneron Pharmaceuticals to Overweight From Neutral, $850 Price Targ..
MT
01/20Analyst recommendations: AIG Chubb, Netflix, Regeneron...
MS
01/19US FDA Approves BeiGene's Lymphocytic Leukemia Treatment
MT
01/19BeiGene's Brukinsa Secures US FDA Approval for Chronic Lymphocytic Leukemia
MT
01/19BeiGene Announces BRUKINSA Approved in the U.S. for Chronic Lymphocytic Leukemia
CI
01/19Insider Sell: Vertex Pharmaceuticals
MT
01/19Piper Sandler Adjusts Price Target on Vertex Pharmaceuticals to $296 From $293, Maintai..
MT
01/19BeiGene Says Brukinsa Gets UK Marketing Authorization for Chronic Lymphocytic Leukemia,..
MT
01/19Brukinsa (Zanubrutinib) Receives Marketing Authorization for Chronic Lymphocytic Leukem..
CI
01/19Four New Indications for BeiGene's Tislelizumab Included in China's Expanded National R..
MT
01/18EU Health Agency Detects No Safety Signals For Pfizer-BioNTech's Updated COVID-19 Shot
MT
01/18BeiGene Says China National Reimbursement Drug List Expanded Coverage of its Drugs
MT
01/18Pasithea Therapeutics Signs Manufacturing Agreement for Drug Candidate PAS-004
MT
01/18Canaccord Genuity Initiates Coverage on Vertex Pharmaceuticals With Hold Rating, $311 P..
MT
01/18BeiGene Announces Expansion of Coverage on China’s National Reimbursement Drug Lis..
CI
01/18Dermapharm falls back from six-week high
DP
01/18Davos 2023: Moderna CEO in talks with China to supply COVID vaccines
RE
01/18Analyst recommendations: Adobe, AstraZeneca, Morgan Stanley, Ora..
MS
01/17Insider Sell: Beigene
MT
01/17SVB Securities Upgrades Vertex Pharmaceuticals to Outperform From Market Perform, Adjus..
MT
01/17Trending: Wuxi Biologics Shareholder Plans Block Sale
DJ
01/17Wuxi Biologics Drops After Major Shareholder Plans to Sell 1.3% Stake
DJ
01/16IG BCE wants drug reserve and 'perspective meeting' with Scholz
DP
01/16BIONTECH : Goldman Sachs reiterates its Neutral rating
MD
01/15US Health Regulators To Probe Pfizer-BioNTech COVID-19 Shot's Potential Link To Stroke
MT
01/13U.S. says Pfizer's bivalent COVID shot may be linked to stroke in older adults
RE
01/13RBC Lifts Price Target on Regeneron Pharmaceuticals to $789 From $782, Maintains Sector..
MT
01/12Insider Sell: Beigene
MT
01/11BioNTech Asks German Court To Cancel CureVac's mRNA Vaccine Patent
MT
01/11Insider Sell: Beigene
MT
01/11Vertex Pharmaceuticals Expands Partnership With Arbor to Cover Precision Gene Editing T..
MT
01/11U.S. to announce list of drugs for pricing negotiations Sept. 1
RE
01/11Pharma Stocks Pull European Equities Lower in Wednesday Trading
MT
01/11BIONTECH : JP Morgan reaffirms its Neutral rating
MD
01/10Insider Sell: Regeneron Pharmaceuticals
MT
01/10Transcript : BioNTech SE Presents at 41st Annual J.P. Morgan Healthcare Confe..
CI
01/10Germany's BioNTech buys British AI startup InstaDeep
RE
01/10BioNTech to Acquire InstaDeep in Cash-and-Stock Deal
MT
Upcoming event on ASCENDIS PHARMA A/S